Sinopharm Jiankun (Beijing) Medical Co., Ltd. announced that it will receive CNY 27,747,400 in a round of funding on October 23, 2019. The transaction will include participation from returning investor from China National Medicines Corporation Ltd. (SHSE:600511). Prior to the transaction, registered capital of the company is CNY 20,000,000. Post closing, the investor will continue to hold 51% stake in the company. The transaction has been approved in the 17th meeting of the 7th directorate of the investor.